These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 23787805

  • 1. Comparison of staging systems for extraocular retinoblastoma: analysis of 533 patients.
    Chantada GL, Sampor C, Bosaleh A, Solernou V, Fandiño A, de Dávila MT.
    JAMA Ophthalmol; 2013 Sep; 131(9):1127-34. PubMed ID: 23787805
    [Abstract] [Full Text] [Related]

  • 2. Metastatic retinoblastoma clinical features, treatment, and prognosis.
    Gündüz K, Müftüoglu O, Günalp I, Unal E, Taçyildiz N.
    Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
    [Abstract] [Full Text] [Related]

  • 3. MRI findings at baseline and after neoadjuvant chemotherapy in orbital retinoblastoma (IRSS stage III).
    Radhakrishnan V, Sharma S, Vishnubhatla S, Bakhshi S.
    Br J Ophthalmol; 2013 Jan; 97(1):52-8. PubMed ID: 23117972
    [Abstract] [Full Text] [Related]

  • 4. Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study.
    Radhakrishnan V, Kashyap S, Pushker N, Sharma S, Pathy S, Mohanti BK, Vishnubhatla S, Ghose S, Bakhshi S.
    Ophthalmology; 2012 Jul; 119(7):1470-7. PubMed ID: 22463820
    [Abstract] [Full Text] [Related]

  • 5. Outcome of children with retinoblastoma and isolated choroidal invasion.
    Bosaleh A, Sampor C, Solernou V, Fandiño A, Domínguez J, de Dávila MT, Chantada GL.
    Arch Ophthalmol; 2012 Jun; 130(6):724-9. PubMed ID: 22801832
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH.
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [Abstract] [Full Text] [Related]

  • 7. Outcome of patients with retinoblastoma and postlaminar optic nerve invasion.
    Chantada GL, Casco F, Fandiño AC, Galli S, Manzitti J, Scopinaro M, Schvartzman E, de Dávila MT.
    Ophthalmology; 2007 Nov; 114(11):2083-9. PubMed ID: 17459482
    [Abstract] [Full Text] [Related]

  • 8. Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastoma.
    Wilson MW, Rodriguez-Galindo C, Billups C, Haik BG, Laningham F, Patay Z.
    Ophthalmology; 2009 Aug; 116(8):1558-63. PubMed ID: 19545904
    [Abstract] [Full Text] [Related]

  • 9. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
    Zhao J, Dimaras H, Massey C, Xu X, Huang D, Li B, Chan HS, Gallie BL.
    J Clin Oncol; 2011 Mar 01; 29(7):845-51. PubMed ID: 21282531
    [Abstract] [Full Text] [Related]

  • 10. Role of PET/CT in staging and evaluation of treatment response after 3 cycles of chemotherapy in locally advanced retinoblastoma: a prospective study.
    Radhakrishnan V, Kumar R, Malhotra A, Bakhshi S.
    J Nucl Med; 2012 Feb 01; 53(2):191-8. PubMed ID: 22251556
    [Abstract] [Full Text] [Related]

  • 11. Results of a prospective study for the treatment of unilateral retinoblastoma.
    Chantada GL, Fandiño AC, Guitter MR, Raslawski EC, Dominguez JL, Manzitti J, de Dávila MT, Zubizarreta P, Scopinaro M.
    Pediatr Blood Cancer; 2010 Jul 15; 55(1):60-6. PubMed ID: 20486172
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
    Uusitalo MS, Van Quill KR, Scott IU, Matthay KK, Murray TG, O'Brien JM.
    Arch Ophthalmol; 2001 Jan 15; 119(1):41-8. PubMed ID: 11146725
    [Abstract] [Full Text] [Related]

  • 13. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
    Kaliki S, Shields CL, Shah SU, Eagle RC, Shields JA, Leahey A.
    Arch Ophthalmol; 2011 Nov 15; 129(11):1422-7. PubMed ID: 22084213
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Results of a prospective study for the treatment of retinoblastoma.
    Chantada G, Fandiño A, Dávila MT, Manzitti J, Raslawski E, Casak S, Schvartzman E.
    Cancer; 2004 Feb 15; 100(4):834-42. PubMed ID: 14770442
    [Abstract] [Full Text] [Related]

  • 16. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
    Luna-Fineman S, Chantada G, Alejos A, Amador G, Barnoya M, Castellanos ME, Fu L, Fuentes-Alabi S, Girón V, Goenz MA, Maldonado C, Méndez G, Morales RA, Ortiz R, Sanchez G, Wilson M, Rodríguez-Galindo C.
    J Clin Oncol; 2019 Nov 01; 37(31):2875-2882. PubMed ID: 31536438
    [Abstract] [Full Text] [Related]

  • 17. Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome.
    Cuenca A, Giron F, Castro D, Fandiño A, Guitter M, de Dávila MT, Chantada G.
    Arch Ophthalmol; 2009 Aug 01; 127(8):1006-10. PubMed ID: 19667337
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic Accuracy of Intraocular Tumor Size Measured with MR Imaging in the Prediction of Postlaminar Optic Nerve Invasion and Massive Choroidal Invasion of Retinoblastoma.
    De Jong MC, van der Meer FJ, Göricke SL, Brisse HJ, Galluzzi P, Maeder P, Sirin S, De Francesco S, Sastre-Garau X, Metz KA, Cerase A, Noij DP, van der Valk P, Moll AC, Castelijns JA, de Graaf P, European Retinoblastoma Imaging Collaboration.
    Radiology; 2016 Jun 01; 279(3):817-26. PubMed ID: 26690907
    [Abstract] [Full Text] [Related]

  • 19. The potential of 3T high-resolution magnetic resonance imaging for diagnosis, staging, and follow-up of retinoblastoma.
    de Jong MC, de Graaf P, Brisse HJ, Galluzzi P, Göricke SL, Moll AC, Munier FL, Popovic MB, Moulin AP, Binaghi S, Castelijns JA, Maeder P, European Retinoblastoma Imaging Collaboration (ERIC).
    Surv Ophthalmol; 2015 Jun 01; 60(4):346-55. PubMed ID: 25891031
    [Abstract] [Full Text] [Related]

  • 20. Minimal Disseminated Disease in Nonmetastatic Retinoblastoma With High-Risk Pathologic Features and Association With Disease-Free Survival.
    Laurent VE, Torbidoni AV, Sampor C, Ottaviani D, Vazquez V, Gabri MR, Garcia de Davila MT, Ramirez-Ortiz MA, Alonso CN, Rossi J, Alonso DF, Chantada GL.
    JAMA Ophthalmol; 2016 Dec 01; 134(12):1374-1379. PubMed ID: 27787537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.